AHR director receives 2,594 restricted stock grant

ESTES SCOTT A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ESTES SCOTT A reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Scott A. Estes reported an equity compensation grant rather than an open-market trade. Upon his re-election to the board, he received 2,594 shares of restricted common stock on June 24, 2026, at no cash cost per share.

The filing shows these restricted shares will vest on June 24, 2027, meaning they fully belong to him on that date if conditions are met. After this award, Estes directly holds 21,489 shares of common stock, giving investors a clearer view of his current equity stake.

Insider Trade Summary

Grant/Award: 2,594 shares

Grant/Award 1 txn

Insider ESTES SCOTT A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,594	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,489 shares (Direct)

Footnotes (1)

1. F1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

Key Figures

Restricted stock grant: 2,594 shares Post-grant holdings: 21,489 shares Grant price: $0.0000 per share +1 more

4 metrics

Restricted stock grant 2,594 shares Grant of restricted common stock on June 24, 2026

Post-grant holdings 21,489 shares Total common stock directly held after transaction

Grant price $0.0000 per share Reported transaction price, indicating a compensation award

Vesting date June 24, 2027 Vesting date for 2,594 restricted common shares

Key Terms

restricted common stock, vest, board of directors, grant, award, or other acquisition

4 terms

restricted common stock financial

"the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026"

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

vest financial

"The reported shares of restricted common stock vest on June 24, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

board of directors financial

"Upon his re-election as a director to the board of directors of the Issuer"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did American Healthcare REIT (AHR) director Scott Estes report?

Scott A. Estes reported an equity award, not a market trade. He received 2,594 shares of restricted common stock as compensation tied to his re-election as director, increasing his direct holdings in American Healthcare REIT.

How many American Healthcare REIT (AHR) shares did Scott Estes receive and at what price?

Scott Estes received 2,594 shares of American Healthcare REIT common stock. The transaction price per share is reported as $0.0000, indicating this was a compensation grant rather than a purchase in the open market.

When do Scott Estes’s restricted American Healthcare REIT (AHR) shares vest?

The 2,594 restricted common shares granted to Scott Estes vest on June 24, 2027. Vesting means the shares become fully his at that time, assuming all service or other vesting conditions are satisfied.

What is Scott Estes’s total American Healthcare REIT (AHR) shareholding after this Form 4?

Following the restricted stock grant, Scott Estes directly holds 21,489 shares of American Healthcare REIT common stock. This total includes the newly granted 2,594 restricted shares reflected in the Form 4 filing.

Was Scott Estes’s American Healthcare REIT (AHR) Form 4 a buy or sell transaction?

The Form 4 does not show a buy or sell in the market. It reports an acquisition coded as a grant or award of 2,594 restricted common shares, provided as equity compensation for his board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 05:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ESTES SCOTT A

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		2,594(1)	A	$0	21,489	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.

	/s/ SCOTT A. ESTES	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)